Tuberculosis (TB) is a chronic bacterial disease caused by Mycobacterium tuberculosis (Mtb). About one third of the world’s population is infected with Mtb, of which only 5-10% develop clinical symptoms and progress to an active disease state. The rest of the population are carriers of the disease, a condition referred to as latent TB infection (LTBI). The transition from latent carriers to active disease can be influenced by many factors such as HIV co-infection, age, co-morbidities such as malaria and other factors, and poses a problem for reliable diagnosis of TB [1].
Genitourinary tuberculosis (GUTB) is a condition that commonly affects humankind, many decades after the onest and treatment of primary tuberculosis. While most countries have achieved a control over spread of the disease, GUTB still poses a diagnostic challenge to most clinicians. The variety of symptoms with which this condition presents with, makes it even more difficult for the treating urologists.